Drew Burdon is a Partner in the EQT Life Sciences team. Drew worked for LSP from 2019 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Prior to joining LSP, Drew worked for 13 years across R&D, commercial/strategy and most recently as a Director of Corporate Development at Smith & Nephew in London, UK. Prior to Smith & Nephew, Drew was a Senior Scientific Officer, at Cancer Research UK in Leeds, UK.
Drew holds a BSc (Hons) In Medical Biochemistry and a PhD in Cell and Molecular Biology, both from the University of Leicester (UK), as-well as an MBA from the Open University (UK).